Pacemaker Market 2022 Size, Top companies Analysis and Technology Update to 2030

 

Pacemaker Market

Pacemaker Market is projected to reach USD 5.7 Billion in 2027 and expected to register a 2.8% CAGR during the forecast period. Surging prevalence of cardiovascular diseases across the globe is the prime drive behind the growth of the global Pacemaker Market. A pacemaker is used in the management of atrial fibrillation, to maintain adequate heart rate. Increasing global geriatric remains a significant growth driver.

The old age population is more prone to developing cardiac disorders and subsequently boosting the growth of the global pacemaker market. Technological advancements in the pacemaker arena have resulted in the development of improved pacemakers with extended battery life, smaller size, better performance, and reduced failure rate. Leadless pacemakers are the new addition to the pacemaker space. They are typically the size of a pill and can be implanted with a minimally invasive procedure. Other driving factors include raising awareness regarding cardiovascular disorders and the general decline in the prices of pacemakers and treatment procedures. The rise in a number of FDA approval for new pacemakers can also be credited for the growth of the market. On the contrary, the growth of the global pacemaker market might be hindered due to the high costs associated with pacemakers which limit market growth in price-sensitive markets. Post-implantation complications of pacemakers are also possible bottlenecks to the growth of the global Pacemaker Market. The market growth is also at a threat from alternative treatment options.

Segmentation

The pacemaker market has been segmented based on product type, application, implant approach, and end user.

·         By product type, the global pacemaker market has been segmented into implantable, and external. The implantable segment has been segmented into single chamber, dual chamber, and biventricular.

·         By application, the global pacemaker market has been segmented into syncope, hypertrophic cardiomyopathy, bradycardia, and heart failure. The bradycardia segment has been further segmented into sinus node dysfunction and AV block.

·         By implant approach, the global pacemaker market has been segmented into endocardial approach and epicardial approach.

·         By end user, the global pacemaker market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

·         Boston Scientific Corporation (U.S.).

Regional Analysis

Geographically, the global pacemaker market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas pacemaker market has been segmented into North America and South America. The Americas is at the forefront of the global pacemaker market due to the high prevalence of cardiovascular disorders in the region which induces greater demand for pacemakers. The region tends to adopt advanced technologies swiftly which coupled with higher affordability drives the market in the Americas.

Europe is the second largest market for a pacemaker. The Europe market is driven by government funding for R&D and the presence of leading market participants in the regions. APAC is slated to be the fastest growing market over the forecast period. The MEA market is likely to exhibit the lowest growth due to limited development in the medical field, lack of technical knowledge, and poor medical facilities.

Industry Updates

December 2018- Carondelet St. Joseph’s Hospital in Tucson, the US is now offering a leadless pacemaker which can be implanted through a minimally invasive surgical procedure. The pacemaker can be used to treat patients with irregular or slower-than-normal heart rate. The new pacemaker is about the size of a vitamin pill and does not require cardiac wires.

Competitive Landscape

Global Pacemaker Market Players include

Biotronik GmbH & Co. KG (Germany), Medtronic Plc (U.S.), Sorin Group, St. Jude Medical Inc. (U.S.), Edwards Lifesciences (U.S.), ATS Medical (U.S.), Vitatron Holding B.V. (the Netherlands), Zoll Medical Corporation (U.S.), and

Related Report-

Global Body Contouring Market Research Report- Forecast To 2027        

Global Erythropoietin Drug Market Research Report- Forecast To 2027 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Hearing Aids Market: In-depth Insights, Revenue Details, Regional Analysis by 2030

Image
  Increasing Prevalence of Hearing Disorders Fuels the Growth of Global Hearing Aids Market As per Market Research Future (MRFR) analysis, The Hearing Aids Market   is predicted to meet at USD 15.32 Billion by 2030 at 8% CAGR during the forecast period (2022-2030). The hearing aid is a battery-powered electronic device intended to enhance hearing capacity. The global market for hearing aids is estimated to expand at a lucrative rate over the forecast period. This can be ascribed to critical factors such as increasing the use of these devices, raising awareness of technologically advanced devices for the treatment of deafness, and growing prevalence of hearing loss due to the rising geriatric population. Key players Some of the major participants in the global Hearing Aids Market Players are Sonova (Switzerland), Cochlear LTD (Australia), GN Store Nord A/S (Denmark), Sivantos PTE. LTD (Singapore), Arphi Electronic PVT (India), Demant AS (Denmark), Starkey Technologies (US), M
Read more

Herbal Medicinal Products Market Analysis 2022 Global Future Outlook 2030, Key Applications, Trends, Top Companies

Image
  Market Overview  The Herbal Medicinal Products Market is expected to reach USD 16,191 Million by 2030 at 12.16% CAGR during the forecast period 2022-2030. Herbal medicinal products are the products are prepared exclusively from the plant source. Herbal plants consist of numerous natural ingredients like polysaccharides, alkaloids, phenols, glycosides, terpenoids, and resins, which are used in herbal medicine formulations owing to its medicinal property. For example, polyphenolic compounds like flavonoids, tannins, and curcumin extracted from herbal plants, which have a good anti-cancer property. Commonly available herbal medicinal products are in the form of capsules, tablets, powder, oils/ointments, and others. Growth Boosters and Key Restraints  Herbal medicines products are dietary supplements or nutraceuticals with health claims in regions like North America, pre-approved by the Food and Drug Administration (FDA). FDA regulations for such products are less strict compare
Read more

Auto-Injectors Market Size, Application, Region and Growth Forecast 2030

Image
  Global Auto-Injectors Market to Post a CAGR of 17.2% Between 2016 and 2022 The Auto-Injectors Market is expected to reach USD 6,753.5 Million by 2030 at 14.2% CAGR during the forecast period 2022-2030. Auto-injectors fall under an important segment of medical devices designed to drug dose delivery in a calculated manner. These injectors are used for delivering life-saving drugs. They are extremely effective in tackling severe allergic reactions. Auto-injectors are one of the several inventions focused toward bettering care giving. The continuous advances in medical technology has led to development of effective auto-injectors. Latest versions of the device are more user-friendly and cost-efficient. These injectors are intended for self-administration by patients. They do not require special training for homecare givers to administer drugs. Such factors make the devices extremely important and practical. The advent of auto-injectors has helped in tackling the challenges faced i
Read more